Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction

Endocrine Reviews

Volumn 23, Issue 3, 2002, Pages 327-364

  Betterle, Corrado ^a   Dal Pra, Chiara ^a   Mantero, Franco ^a   Zanchetta, Renato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX ANTIBODY; ALDOSTERONE; AUTOANTIBODY; AUTOANTIGEN; CORTICOTROPIN RECEPTOR ANTIBODY; CORTISONE; ENZYME ANTIBODY; EPITOPE; FLUDROCORTISONE; HYDROCORTISONE; HYDROCORTISONE ANTIBODY; RECEPTOR ANTIBODY; STEROID 21 MONOOXYGENASE; STEROID 21 MONOOXYGENASE ANTIBODY; STEROID PRODUCING CELL ANTIBODY; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ALGORITHM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE ENDOCRINE ADENOMATOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION; AUTOIMMUNE POLYENDOCRINOPATHY; IMMUNOLOGY; PROGNOSIS;

ADRENAL INSUFFICIENCY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROGNOSIS;

EID: 85047684725     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.23.3.0466     Document Type: Review

References (330)

1. Autoimmune vitiligo. Detection of antibodies to melanin-producing cells
2. Bronze Addison's disease
3. Adrenal insufficiency
4. Addison's disease, adrenal autoantibodies and computerized adrenal tomography
5. Is the prevalence of Addison's disease underestimated?
6. Addison's disease-clinical studies. A report of 108 cases
7. Epidemiological and clinical picture of Addison's disease
8. Eighty-six cases of Addison's disease
9. The prevalence of Addison's disease in Coventry, UK
10. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
11. Addison's disease
12. A clinical and immunological study of adrenocortical insufficiency (Addison's disease)
13. Serum TSH and thyroid studies in Addison's disease
14. Addison's disease
15. A clinical study of Addison's disease
16. Morbo di Addison: Principali associazioni cliniche e descrizione della storia naturale della malattia
17. Polyglandular autoimmune syndrome type II in patients with idiopathic Addison's disease
18. Association of Addison's disease with autoimmune disorders - A long-term observation of 180 patients
19. Associated autoimmunity in Addison's disease
20. Adrenal autoantibodies and organ-specific autoimmunity in Addison disease
21. The causes of autoimmune thyroid disease
22. Addison's disease
23. Diseases of the adrenal cortex
24. Adrenal complications of HIV infection
25. A "primary" antiphospholipid syndrome?
26. Adrenocortical insufficiency
27. X-linked adrenoleukodystrophy
28. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy
29. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
30. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor
31. Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: Relationships with clinical features in four families
32. Novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome
33. Clinical review 130: Addison's disease 2001
34. Chronic thyroiditis and autoimmunization
35. Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
36. Generalità sulle malattie autoimmuni
37. Autoantibodies in Addison's disease
38. Addison's disease, ovarian failure and hypoparathyroidism
39. Autoimmune diseases of the adrenals, gonads, and parathyroids: Autoimmune polyendocrine disease
40. Advances in the genetic and immunology of autoimmune polyglandular syndrome II/III and their clinical applications
41. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity
42. The autoimmune basis of adrenocortical destruction in Addison's disease
43. Adrenalitis, oophoritis and autoimmune polyglandular disease
44. Review article: Adrenal and ovarian autoimmunity
45. Histopathology of adrenal gland in Addison's disease
46. Cellular immunity in autoimmune thyroid disease
47. Focal lymphocytic infiltration in the adrenal cortex of the elderly: Immunohistochemical analysis of infiltrating lymphocytes
48. Anti-adrenal cellular hypersensitivity in Addison's disease. 2. Correlation with clinical and serological findings
49. The role of autoimmunity in hypoendocrine and hyperendocrine function: With special emphasis on autoimmune thyroid disease
50. Anti-adrenal cellular hypersensitivity in Addison's disease. Species specificity and subcellular localization of the antigen
51. Anti-adrenal cellular hypersensitivity in Addison's disease. IV. In vitro and in vivo investigation of the mitochondrial fraction
52. Immunoregulation abnormalities in familial Addison's disease
53. Decreased suppressor cell activity in patients with polyglandular failure
54. Ia-positive T lymphocytes in recently diagnosed idiopathic Addison's disease
55. T and B cell reactivity to adrenal antigens in autoimmune Addison's disease
56. Experimental autoimmune adrenalitis: A murine model for Addison's disease
57. The production and passive transfer of allergic adrenalitis
58. The fate of newly formed lymphocytes migrating from an antigen-stimulated lymph node in rats with allergic adrenalitis
59. Eine biglandulare erkrankung (nebennieren und schilddrüse) bei Morbus Addisonii
60. Schmidt's syndrome (thyroid and adrenal insufficiency): A review of the literature and a report of fifteen new cases including ten instances of co-existent diabetes mellitus
61. A clinical study of Addison's disease
62. Addison's disease with diabetes mellitus
63. Diabetes mellitus and Addison's disease. A report of 8 patients and a review of 55 cases in the literature
64. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes
65. Chronic tetany and chronic mycelial stomatitis in a child aged 4 and half years
66. Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis
67. The syndrome of familial juvenile hypoadrenocorticism, hypoparathyroidism and superficial moniliasis
68. Idiopathic hypoparathyroidism: Case reports and review of the literature
69. Polyglandular autoimmune diseases
70. Virus-induced diabetes mellitus. Polyendocrinopathy and autoimmunity
71. Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine tissue
72. Multiple autoantibodies following cytomegalovirus infection: Virus distribution and specificity of autoantibodies
73. Organspecific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease
74. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease
75. Predisposition to organ-specific autoimmunity in obese strain (OS) chickens: Reactivity to thyroid, gastric, adrenal and pancreatic cytoplasmic antigens
76. Histological and immunological changes in the thymus and other organs in NOD mice
77. Parathyroiditis in the non-obese diabetic mouse - A new finding
78. Polyglandular deficiency syndrome in a boxer dog: Thyroid hormone and glucocorticoid deficiency
79. Insuffisance pluriglandulaire endocrinienne
80. Zur kenntnis der lymphomatosen veranderung der schilddruse (struma lymphomatosa)
81. Uber "insulitis" bei diabetes
82. Addison's disease associated with thyroid insufficiency and atrophy
83. Autoantibodies in Hashimoto's disease
84. Studies in organ specificity. V. Changes in the thyroid glands of rabbit following active immunization with rabbit thyroid extracts
85. Abnormal responses in the assay of thyrotropin
86. Inactivation of long-acting thyroid stimulator (LATS) by anti-κ anti-λ antisera
87. Autoantibodies to the thyrotropin receptor
88. Tolerance and autoimmunity
89. Embryonal germ-layer antigens: Target for autoimmunity
90. Polyendocrine autoimmunity
91. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED): Autosomal recessive inheritance
92. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
93. Clinical review: Autoimmune polyglandular disease type 1
94. Polyglandular autoimmune syndrome type I among Iranian Jews
95. Cytochrome P450 IA2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1
96. Type 1 autoimmune polyglandular disease
97. Juvenile autoimmune polyendocrinopathy
98. Detection of candidal antigens in autoimmune polyglandular syndrome type 1
99. Candidiasis-endocrinopathy syndrome
100. Autoimmune polyendocrine syndrome type 1 (APS I) in Norway
101. Primary immunodeficiency diseases
102. A prospective cytogenetic study of 36 cases of Di George syndrome
103. GATA3 haplo-insufficiency causes human HDR syndrome
104. The autosomal recessive Kenny-Caffey syndrome locus maps to chromosome 1q42-q43
105. Familial nephrosis, nerve deafness, and hypoparathyroidism
106. Primary immune deficiency diseases
107. Familial isolated hypoparathyroidism: A molecular genetic of 8 families with 23 affected persons
108. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism
109. Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies
110. The syndrome of keratokonjunctivitis superficial moniliasis idiopathic hypoparathyroidism and Addison's disease
111. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism
112. Antibody to the oxyphil cells of the human parathyroid in idiopathic hypoparathyroidism
113. Do parathyroid and adrenal autoantibodies coexist?
114. A human specific mithochondrial antibody. Its importance in the identification of organ-specific reactions
115. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions
116. Primary biliary cirrhosis
117. Parathyroid cell surface antibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells
118. Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism
119. Anti-endothelial cell antibodies: Detection and characterization in sera from patients with autoimmune hypoparathyroidism
120. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism
121. Is idiopathic hypoparathyroidism an autoimmune disease?
122. Assessment of enamel hypoplasia in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
123. Organ-specific and non-organ-specific autoanti-bodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
124. Chronic active hepatitis in the type 1 polyglandular autoimmune syndrome
125. Two cytochrome P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1
126. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type 1
127. Antibodies to melanocyte in vitiligo
128. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type 1
129. Antibodies to glutamic acid decarboxylase and insulin dependent diabetes in patients with autoimmune polyendocrine syndrome type 1
130. β-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
131. Idiopathic hypoparathyroidism
132. Familial hypoparathyroidism with pernicious anemia, steatorrhea and adrenocortical insufficiency
133. Idiopathic hypoparathyroidism and idiopathic adrenal cortical insufficiency occurring with cystic fibrosis
134. Moniliasis an internal disease? Three cases of idiopathic hypoparathyroidism with moniliasis, steatorrhea, primary amenorrhea and pernicious anemia
135. Autoimmune polyendocrine candidiasis syndrome with associated chronic diarrhea caused by intestinal infection and pancreas insufficiency
136. Intestinal lymphangectasia in a patient with autoimmune polyglandular disease type 1 and steatorrhea
137. Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated with immunosuppression
138. Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: Response to immunosuppressive therapy
139. Identification of tryptophan hydroxylase as an intestinal autoantigen
140. Pteridin-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1
141. Malabsorption due to cholecystokin deficiency in a patient with autoimmune polyglandular syndrome type 1
142. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type 1
143. Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphatase-dependent enzyme, is a β-cell autoantigen
144. Autoantibodies against aromatic-L-amino acid decarboxylase in autoimmune polyendocrine syndrome type 1
145. Autoantibodies to prolactin-secreting cells of human pituitary
146. Melanin-producing cell autoantibodies: Predictive marker of autoimmune vitiligo
147. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2, and 4
148. Clinical and genetic heterogeneity in idiopathic Addison's disease and hypoparathyroidism
149. Genetic heterogeneity in autoimmune polyglandular failure
150. Three sisters with Addison's disease
151. Familial distributions of organ specific antibodies in the blood of patients with Addison's disease and hypoparathyroidism and their relatives
152. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR
153. The polyglandular deficiency syndrome: A new variant in Persian Jews
154. A cytotoxic T lymphocytic antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients
155. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21
156. Positional cloning of the APECED gene
157. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
158. APECED mutations in the autoimmune regulator (AIRE) gene
159. APECED: A monogenic autoimmune disease providing new clues to self-tolerance
160. Common mutations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients of different origins
161. Mutation analyses of North American APS-1 patients
162. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1)
163. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy patients
164. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1
165. Mutations in the AIRE gene: Effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein
166. Novel mutations of the autoimmune regulator gene in two siblings with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
167. The autoimmune polyglandular syndromes
168. The autoimmune regulator protein has transcriptional transactivating properties and interereacts with the common coactivator CREB-binding protein
169. Type 2 polyglandular autoimmune disease
170. Thyroid autoantibodies: A good marker for the study of symptomless autoimmune thyroiditis
171. Complement-fixing gastric parietal cell autoantibodies. A good marker for the identification of the type A chronic atrophic gastritis
172. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: Markers of low progression to clinical Addison's disease
173. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: Markers of high progression to clinical Addison's disease
174. The polyglandular failure syndrome: Disease inheritance, HLA-type, and immune function studies in patients and families
175. Immunogenetics of autoimmune polyglandular syndromes
176. The HLA system. First of two parts
177. The HLA system. Second of two parts
178. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease
179. HLA antigens in idiopathic Addison's disease
180. The immunology and genetics of autoimmune endocrine disease
181. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigen-DR3 and/or DR4, except when associated with type 1 autoimmune polyendocrine syndrome
182. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and DQB1 are shared in endocrine autoimmune disease
183. Addison's diseases: Immunological aspects
184. The HLA-DQβ non-Asp-57 allele: A predictor of future insulin-dependent diabetes mellitus in patients with autoimmune Addison's disease
185. HLA associations with autoimmune Addison's disease
186. Major histocompatibility complex class II and III in Addison's disease
187. Although DR3-DQB1 0201 may be associated with multiple component diseases of the autoimmune polyglandular syndrome, the human leukocyte antigen DR4-DQB1 0302 haplotype is implicated only in β-cells autoimmunity
188. Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease
189. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4
190. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes
191. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 in Hashimoto's thyroiditis and Addison's disease
192. CTLA-4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
193. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease
194. Sindromi pluriendocrine autoimmuni
195. Studies of the adrenal antigens and autoantibodies in Addison's disease
196. Anticorpi anti-surrene nel morbo di Addison
197. Autoantibodies in Addison's disease
198. Serological investigation on Addison's disease
199. Anticorps antisurrénaliens et maladie d'Addison
200. The incidence of adrenal and other autoantibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease)
201. Immunologic aspect of adrenocortical insufficiency
202. Addison's disease and associated conditions: With particular references to premature ovarian failure, diabetes mellitus and hypoparathyroidism
203. Gonadal autoantibodies in patients with hypogonadism and/or Addison disease
204. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility
205. An ELISA method for the detection of autoantibodies to adrenal cortex
206. A radioimmunoassay for the detection of adrenal autoantibodies
207. Serological markers in Addison's disease
208. IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability
209. Adrenal-cortex autoantibodies (ACA) and steroid-producing cells autoantibodies (StCA) in patients with Addison's disease: Comparison between immunofluorescence and immunoprecipitation assays
210. Novel considerations on the antibody/autoantigen system in type 1 (insulin-dependent) diabetes mellitus
211. Immunoprecipitation of human adrenal microsomal antigen
212. Identification by molecular cloning of an autoantigen associated with Addison's disease as steroid 17α-hydroxylase
213. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease
214. Autoimmune Addison's disease and 21-hydroxylase
215. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease
216. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome. Addison's disease and premature ovarian failure
217. Autoimmune adrenal diseases - A new sensitive assay for measurement of steroid 21-hydroxylase autoantibodies
218. Autoantibody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease
219. Autoantibodies to cytochrome P450 enzymes p450 scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease
220. A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addison's disease
221. Immunoprecipitation of steroidogenic enzyme autoantigens with autoimmune polyglandular syndrome type I (APS I) sera; further evidence for humoral immunity to P450 c17 and P450 21
222. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase
223. 21-Hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease
224. Direct evidence that steroid 21-hydroxylase (21-OH) is the major antigen recognized by adrenal cortex autoantibodies (ACA)
225. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II
226. Identification of 3β-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: Association of autoantibodies with endocrine autoimmune disease
227. 3β-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure
228. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays
229. Insulin autoantibodies measured by radioimmunoassay methodology are more related to IDDM than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement
230. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second International GADAb Workshop
231. Autoanticorpi nella menopausa precoce
232. Development of adrenocortical failure in non-addisonian patients with antibodies to adrenal cortex
233. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease
234. Adrenal dysfunction in asymptomatic patients with adrenocortical antibodies
235. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies
236. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus
237. Autoantibodies against recombinant human steroidogenic enzymes 21-hydroxylase, side chain cleavage and 17α-hydroxylase in Addison's disease and autoimmune polyendocrine syndrome type III
238. Adrenal antibodies and Addison's disease in insulin-dependent diabetes mellitus
239. Progressive adrenal failure in polyglandular autoimmune disease
240. The diagnosis and staging of hypocortisolism in progressing autoimmune adrenalitis
241. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies
242. Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease
243. Time course of 21-hydroxylase autoantibodies and long term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: Case report
244. Prevention of type 1 diabetes and recurrent β-cell destruction of transplanted islets
245. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
246. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor β for Crohn's disease
247. Randomised double-blind placebo-controlled study by interferon β-1a in relapsing/remitting multiple sclerosis
248. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes
249. Screening patients with insulin-dependent diabetes mellitus for adrenal insufficiency
250. DRB1*04 and DQ alleles: Expressions of 21-hydroxylase autoantibodies and risk of progressions to Addison's disease
251. Etiological diagnosis of primary adrenal insufficiency using an original flowchart of immune and biochemical markers
252. Clinical problem-solving. Just in time
253. Cushing's syndrome with adrenal medullary insufficiency and adrenal autoantibodies
254. Cushing's syndrome and autoimmunity
255. Immunoglobulins of patients with Cushing's syndrome due to pigmented adrenocortical micronodular dysplasia stimulate the steroid production of guinea-pig adrenal segments kept in organ culture
256. Review article. Mechanisms of disease. Receptor autoimmunity in endocrine disorders
257. Immunological features of idiopathic Addison's disease: An antibody to cells producing steroid hormones
258. The cytotoxic effect of the serum from patients with Addison's disease and autoimmune ovarian failure on human granulosa cells in culture
259. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease
260. Premature ovarian failure and ovarian autoimmunity
261. Autoimmunity in endocrine disease
262. Premature ovarian failure: Evidence for the autoimmune mechanisms
263. Autoimmune oophoritis
264. Lymphocyte dysfunction in autoimmune oophoritis; resumption of menses with corticosteroids
265. Autoimmune oophoritis: A histological study involved ovaries with immunologic characterization of the mononuclear infiltrate
266. Case record of the Massachusett's General Hospital, case 46-1987
267. Premature menopause associated with autoimmune oophoritis. Case report
268. Cystic ovarian enlargement resulting from autoimmune oophoritis
269. Autoimmune oophoritis: A clinicopathological assessment of 12 cases
270. Autoimmune oophoritis associated with polycystic ovaries
271. Enzymes as autoantigens
272. Premature ovarian failure: Autoimmunity and natural history
273. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease
274. Identification of the main gonadal autoantigens in the patients with adrenal insufficiency and associated ovarian failure
275. Autoantigens in the autoimmune endocrinopathies
276. Adrenal and gonadal autoimmune diseases
277. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure
278. Autoimmune etiology in premature ovarian failure
279. Hypergonadotropic forms of amenorrhea in young women
280. Premature ovarian failure: Its relationship to autoimmune diseases
281. Characterization of idiopathic premature ovarian failure
282. A new syndrome of amenorrhea in association with hypergonadotropism and apparently normal ovarian follicular apparatus
283. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins
284. Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: Suggestion of similar autoimmune mechanisms
285. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome?
286. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure
287. Premature menopause. I. Etiology
288. Prevalence of circulating antibodies directed towards ovaries among women with premature ovarian failure
289. Circulating antiovarian antibodies in premature ovarian failure
290. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure
291. Occult ovarian failure: Syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations
292. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone receptor complex of bovine corpus luteum
293. Detection of antibodies to ovarian antigens in women with premature ovarian failure
294. Premature ovarian failure, current concepts
295. Deletions of Xq and growth deficit: A review
296. Molecular and cytogenetic studies of an X autosome translocation in a patient with premature ovarian failure and review of the literature
297. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
298. Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase
299. Naturally occurring mutations in human 21-hydroxylase influence adrenal autoantibody binding
300. A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease
301. A conformational-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase
302. Analysis of autoantibody epitopes on steroid 21-hydroxylase (21-OH) using a panel of monoclonal antibodies
303. The molecular biology of cytochrome P450s
304. The principles, pathways, and enzymes of human steroidogenesis
305. Molecolar biology of steroid hormone synthesis
306. The adrenal glands and extra-adrenal paraganglia
307. Autoimmune Addison's disease. Evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency
308. Hormonal responses during various phases of autoimmune adrenal failure: No evidence for 21-hydroxylase enzyme activity in vivo
309. Immunological studies in the neonate of a mother with Addison's disease and diabetes mellitus
310. Management of congenital hypothyroidism
311. Transient neonatal hypothyroidism: Characterization of maternal antibodies to the thyrotropin receptor
312. Neonatal transient hypothyroidism: Etiological study
313. Surface-reactive antibodies to human adrenal cells in Addison's disease
314. Immunoglobulins of patients with Addison's disease block the in vitro action of adrenocorticotropin
315. Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease
316. Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: A reexamination
317. Organ-specific autoimmunity
318. Anti-corticosteroid antibodies in AIDS patients
319. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: Studies of seventy autopsied cases
320. Insulin-dependent diabetes mellitus as an autoimmune disease
321. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity
322. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
323. Lack of immunohistological changes in the islet of nondiabetic, autoimmune, polyendocrine patients with β-selective GAD-specific islet cell antibodies
324. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes
325. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
326. Malattie autoimmuni del surrene
327. Adrenal imaging